SCHOLAR ROCK HLDG CORP's ticker is SRRK and the CUSIP is 80706P103. A total of 111 filers reported holding SCHOLAR ROCK HLDG CORP in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $165,792 | +45.9% | 23,351 | +55.0% | 0.00% | 0.0% |
| Q2 2023 | $113,628 | -46.9% | 15,070 | -9.2% | 0.00% | 0.0% |
| Q1 2022 | $214,026 | -20.0% | 16,604 | +54.1% | 0.00% | -50.0% |
| Q4 2021 | $267,576 | -24.8% | 10,772 | 0.0% | 0.00% | -33.3% |
| Q3 2021 | $355,691 | +14.3% | 10,772 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $311,311 | -43.0% | 10,772 | 0.0% | 0.00% | -40.0% |
| Q1 2021 | $545,710 | +4.4% | 10,772 | 0.0% | 0.01% | 0.0% |
| Q4 2020 | $522,765 | +174.3% | 10,772 | 0.0% | 0.01% | +150.0% |
| Q3 2020 | $190,557 | -2.9% | 10,772 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $196,158 | +93.2% | 10,772 | +28.5% | 0.00% | +100.0% |
| Q1 2020 | $101,506 | -19.7% | 8,382 | +5.2% | 0.00% | 0.0% |
| Q2 2019 | $126,372 | -15.6% | 7,968 | 0.0% | 0.00% | -50.0% |
| Q1 2019 | $149,719 | – | 7,968 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Artal Group S.A. | 2,450,000 | $31,581,000 | 1.32% |
| Logos Global Management LP | 675,000 | $8,701,000 | 1.13% |
| Samsara BioCapital, LLC | 339,611 | $4,378,000 | 1.10% |
| Redmile Group, LLC | 2,407,326 | $31,030,000 | 0.97% |
| Bellevue Group AG | 2,184,425 | $28,157,000 | 0.33% |
| Frazier Life Sciences Management, L.P. | 156,000 | $2,011,000 | 0.17% |
| Atom Investors LP | 25,839 | $333,000 | 0.16% |
| GSA CAPITAL PARTNERS LLP | 32,010 | $413,000 | 0.06% |
| Tekla Capital Management LLC | 108,833 | $1,403,000 | 0.05% |
| Virtus ETF Advisers LLC | 6,212 | $80,000 | 0.04% |